ArticleOcular oncology and pathology2023

Mitogen-Activated Pathway Kinase Inhibitor-Associated Retinopathy: Do Features Differ with Upstream versus Downstream Inhibition?

Jasmine H Francis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.